DMC makes headway on fundraising goal
BOULDER — DMC Biotechnologies Inc. has raised more than a third of its latest fundraising goal in just under two weeks.
The Boulder-based company has raised $4,649,995 from three investors out of its $12 million goal, according to filings with the U.S. Securities and Exchange Commission.
DMC is developing a process to rapidly engineer microbial hosts that can be used to synthesize specialized chemicals for flavorings, fragrances, pharmaceuticals and other industries.
SPONSORED CONTENT
Empowering communities
Rocky Mountain Health Plans (RMHP), part of the UnitedHealthcare family, has pledged its commitment to uplift these communities through substantial investments in organizations addressing the distinct needs of our communities.
DMC most recently completed a $2,537,660 fundraising round in March and raised $1,333,333 out of a $2,499,999 goal in January 2018, according to SEC filings.
The company did not respond to a request for comment Friday morning.
BOULDER — DMC Biotechnologies Inc. has raised more than a third of its latest fundraising goal in just under two weeks.
The Boulder-based company has raised $4,649,995 from three investors out of its $12 million goal, according to filings with the U.S. Securities and Exchange Commission.
DMC is developing a process to rapidly engineer microbial hosts that can be used to synthesize specialized chemicals for flavorings, fragrances, pharmaceuticals and other industries.
DMC most recently completed a $2,537,660 fundraising round in March and raised $1,333,333 out of a $2,499,999 goal in January 2018, according to SEC filings.
The company did not respond to a request…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
